Diamonds Are Forever, but TKIs in CML Don ' t Have to Be Diamonds Are Forever, but TKIs in CML Don ' t Have to Be
Patients with chronic myeloid leukemia who undergo lifelong therapy with tyrosine kinase inhibitors have excellent outcomes. But treatment may not have to be forever.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Health | Hematology | Leukemia